| 參考文獻 |
1
|
Chen L-S, Yen AM-F, Chiu SY-H, Liao C-S, Chen H-H. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011; S1470-2045(11)70101-2
|
2
|
Chiu HM, Chen SLS, Yen AMF, et al. Koong SL, Chiou ST*. Effectiveness of Fecal Immunochemical Testing Reducing Colorectal Cancer Mortality from One million Taiwanese Screening Program. Cancer. 2015 Sep 15;121(18):3221-9
|
3
|
Evelyn P. Whitlock et al. Screening for colorectal cancer: A targeted, updated systematic review for the U.S. preventive services Task Force. Annals of Internal Medicine;2008;149;638-658
|
4
|
Fraser C G, Matthew C M N, Mowat A G et al. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncology; 2006; 7:127-131
|
5
|
Hardcastle JD, Chamberlain JO, Robinson MH et al. Balfour TW, James PD, Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
|
6
|
Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. New England Journal Medicine; 2004, 351:2704-2714.
|
7
|
Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet 1996, 348:1467-71. Kirschner CG, Davis SJ, Duffy C et al. Current Procedural Terminology: CPT. Chicago: American Medical Association; 1999.
|
8
|
Lieke Hol et al. Screening For Colorectal Cancer; Randomised Trial Comparing Guaiac-Based And Immunochemical Faecal Occult Blood Testing And Flexible Sigmoidoscopy Gut, 2009, Aug
|
9
|
Levin B, David A. L, Mcfarland B. et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology;2008,134:1570–1595
|
10
|
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. New England Journal Medicine; 1993,328:1365-1371.
|
11
|
Michael Pignone et al. Screening for colorectal cancer in asults at average risk: A summary of the evidence for the U.S. preventive services Task Force. Annals of Internal Medicine;2002;137;132-141
|
12
|
Mandel J S. Which Colorectal Cancer Screening Test Is Best? Journal of the National Cancer Institute, 2007;99(19);1424-1425
|
13
|
Pignone M, Saha S, Hoerger T, Mandelblatt J: Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine; 2002, 137:96-104.
|
14
|
Rabeneck L, Pazat LF., Hilsden R J. et al. Bleeding and Perforation After Outpatient Colonoscopy and Their Risk Factors in Usual Clinical Practice. Gastroenterology;2008;135;1899-1906
|
15
|
Robert A. Smith, Vilma Cokkinides, Otis W. Brawley. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening. CA: Cancer Journal Clinical; 2009;59;27-41
|
16
|
Rex D K., Cutler C S., Lemmel G T. et al Colonoscopic Miss Rates of Adenomas Determined by Back-to-Back Colonoscopies. Gastroenterology;1997;114:24-28
|
17
|
Rex DK, Boland CR2, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 Jul;112(7):1016-1030
|
18
|
Traverso G et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. The New England journal of medicine; 2002, 346,311-320
|
19
|
Theodore R. Levin, Wei Zhao, Carol Conell, et al. Complications of Colonoscopy in an Integrated Health Care Delivery System. Annals of Internal Medicine; 2006,145:880-887
|
20
|
van Gossum A, Navas M M, Inaqui F-U et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. The New England journal of medicine; 2009,361(3):264-270
|
21
|
Winawer SJ, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology; 1997, 112:594-642
|
22
|
Wu Grace Hui-Min, Wang Yi-Ming, Yen Amy Ming-Fang Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries BMC Cancer; 2006, 6:136-141
|
23
|
大腸直腸癌診斷與治療之共識國家衛生研究院;1998
|
24
|
衛生福利部國民健康署 篩檢工作指引第二章
|
25
|
國家衛生研究院 NHRI/TCOG Cancer Practice Guideline
|